Moleculin Biotech (MBRX) Other Non-Current Liabilities (2016 - 2026)
Moleculin Biotech (MBRX) reported Other Non-Current Liabilities of $40,000 for Q2 2026, down 99.8% from $16.97 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
At the end of FY2025, Moleculin Biotech posted Other Non-Current Liabilities of $44,000.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -64.8% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $4.86 million in FY2023, $77,000 in FY2022 (-94.5%) and $1.41 million in FY2021 (-82.8%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q3 2023.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q2 2025 (growth of 896.1%); the low point was Q2 2026 (a decline of 99.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Moleculin Biotech | 2.84 Mn | 2.84 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 41.33 Mn |
| Jun 30, 2025 | 16.97 Mn |
| Sep 30, 2024 | 9.93 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 77,000.00 |
| Sep 30, 2022 | 228,000.00 |
| Jun 30, 2022 | 649,000.00 |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 1.41 Mn |
| Sep 30, 2021 | 3.71 Mn |
| Jun 30, 2021 | 5.39 Mn |
| Mar 31, 2021 | 6.56 Mn |
| Dec 31, 2020 | 8.19 Mn |
API Access
Moleculin Biotech Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();